Tero Aittokallio

Novel Targeted Therapies for Granulosa Cell Tumors Using High-Throughput Drug Screen of Primary Tumor Cells (2014)

Reproductive Sciences

Haltia UM, Andersson N, Yadav B, Kulesskiy E, Hintsanen P, Farkkila A, Riska A, Unkila-Kallio L, Wennerberg K, Aittokallio T, Anttonen M

(O2 Muu julkaisu )

Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model (2014)

PLoS ONE

Yatkin E, Polari L, Laajala TD, Smeds A, Eckerman C, Holmbom B, Saarinen N, Aittokallio T, Mäkelä S.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A community effort to assess and improve drug sensitivity prediction algorithms (2014)

Nature Biotechnology

Costello JC, Heiser LM, Georgii E, Gonen M, Menden MP, Wang NJ, Bansal M, Ammad-ud-din M, Hintsanen P, Khan SA, Mpindi JP, Kallioniemi O, Honkela A, Aittokallio T, Wennerberg K, Collins JJ, Gallahan D, Singer D, Saez-Rodriguez J, Kaski S, Gray JW, Stolovitzky G

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia (2014)

Proteomics

Elo LL, Karjalainen R, Ohman T, Hintsanen P, Nyman TA, Heckman CA, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles (2014)

Current Pharmaceutical Design

Tang J, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Systematic high-throughput drug sensitivity and resistance testing (DSRT) of ovarian cancer cell lines indicates novel therapeutic possibilities with existing and emerging drugs (2014)

Cancer Research

Hirasawa A, Murumagi A, Arjama M, Yadav B, Mpindi JP, Wennerberg K, Aittokallio T, Aoki D, Kallioniemi O

(O2 Muu julkaisu )

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling (2013)

Blood

Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A, Almusa H, Bespalov M, Ellonen P, Elonen E, Gjertsen BT, Karjalainen R, Kulesskiy E, Lagstrom S, Lehto A, Lepisto M, Lundan T, Majumder MM, Marti JML, Mattila P, Murumagi A, Mustjoki S, Palva A, Parsons A, Pirttinen T, Ramet ME, Suvela M, Turunen L, Vastrik I, Wolf M, Knowles J, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K

(O2 Muu julkaisu )

Identifying prognostically relevant subsets of endometrial cancer using unsupervised clustering of immunohistochemical staining data (2013)

Virchows Archiv

Huvila J, Laajala D, Edqvist PH, Talve L, Grenman S, Ponten F, Aittokallio T, Carpen O, Auranen A

(O2 Muu julkaisu )

Development of a drug sensitivity testing pipeline towards the establishment of precision medicine for ovarian cancer (2013)

Clinical Cancer Research

Hirasawa A, Murum,Gi A, Yadav B, Mpindi JP, Mariliina A, Aittokallio T, Wennerberg K, Aoki D, Kallioniemi O

(O2 Muu julkaisu )

Genetic variants and their interactions in disease risk prediction - machine learning and network perspectives (2013)

BioData Mining

Okser S, Pahikkala T, Aittokallio T

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Novel Targeted Therapies for Granulosa Cell Tumors Using High-Throughput Drug Screen of Primary Tumor Cells (2014)

Novel Lignan and Stilbenoid Mixture Shows Anticarcinogenic Efficacy in Preclinical PC-3M-luc2 Prostate Cancer Model (2014)

A community effort to assess and improve drug sensitivity prediction algorithms (2014)

Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia (2014)

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles (2014)

Systematic high-throughput drug sensitivity and resistance testing (DSRT) of ovarian cancer cell lines indicates novel therapeutic possibilities with existing and emerging drugs (2014)

Identification Of AML Subtype-Selective Drugs By Functional Ex Vivo Drug Sensitivity and Resistance Testing and Genomic Profiling (2013)

Identifying prognostically relevant subsets of endometrial cancer using unsupervised clustering of immunohistochemical staining data (2013)

Development of a drug sensitivity testing pipeline towards the establishment of precision medicine for ovarian cancer (2013)

Genetic variants and their interactions in disease risk prediction - machine learning and network perspectives (2013)